ID CHD1_MOUSE Reviewed; 1711 AA. AC P40201; Q14BJ0; DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot. DT 27-JUL-2011, sequence version 3. DT 27-MAR-2024, entry version 181. DE RecName: Full=Chromodomain-helicase-DNA-binding protein 1; DE Short=CHD-1; DE EC=3.6.4.12; DE AltName: Full=ATP-dependent helicase CHD1; GN Name=Chd1; Synonyms=Chd-1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=8460153; DOI=10.1073/pnas.90.6.2414; RA Delmas V., Stokes D.G., Perry R.P.; RT "A mammalian DNA-binding protein that contains a chromodomain and an RT SNF2/SWI2-like helicase domain."; RL Proc. Natl. Acad. Sci. U.S.A. 90:2414-2418(1993). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP SUBCELLULAR LOCATION, AND DNA-BINDING. RX PubMed=7739555; DOI=10.1128/mcb.15.5.2745; RA Stokes D.G., Perry R.P.; RT "DNA-binding and chromatin localization properties of CHD1."; RL Mol. Cell. Biol. 15:2745-2753(1995). RN [5] RP SUBCELLULAR LOCATION, DOMAIN, AND INTERACTION WITH SSRP1. RX PubMed=10199952; DOI=10.1007/s004120050347; RA Kelley D.E., Stokes D.G., Perry R.P.; RT "CHD1 interacts with SSRP1 and depends on both its chromodomain and its RT ATPase/helicase-like domain for proper association with chromatin."; RL Chromosoma 108:10-25(1999). RN [6] RP INTERACTION WITH BCLAF1; NCOR; SRP20 AND SAF-B, AND FUNCTION. RX PubMed=12890497; DOI=10.1016/s0006-291x(03)01354-8; RA Tai H.H., Geisterfer M., Bell J.C., Moniwa M., Davie J.R., Boucher L., RA McBurney M.W.; RT "CHD1 associates with NCoR and histone deacetylase as well as with RNA RT splicing proteins."; RL Biochem. Biophys. Res. Commun. 308:170-176(2003). RN [7] RP FUNCTION, AND INTERACTION WITH CHROMATIN. RX PubMed=19587682; DOI=10.1038/nature08212; RA Gaspar-Maia A., Alajem A., Polesso F., Sridharan R., Mason M.J., RA Heidersbach A., Ramalho-Santos J., McManus M.T., Plath K., Meshorer E., RA Ramalho-Santos M.; RT "Chd1 regulates open chromatin and pluripotency of embryonic stem cells."; RL Nature 460:863-868(2009). RN [8] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214 AND SER-215, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Lung, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: ATP-dependent chromatin-remodeling factor which functions as CC substrate recognition component of the transcription regulatory histone CC acetylation (HAT) complex SAGA. Regulates polymerase II transcription. CC Also required for efficient transcription by RNA polymerase I, and more CC specifically the polymerase I transcription termination step. Regulates CC negatively DNA replication. Not only involved in transcription-related CC chromatin-remodeling, but also required to maintain a specific CC chromatin configuration across the genome. Required for the bridging of CC SNF2, the FACT complex, the PAF complex as well as the U2 snRNP complex CC to H3K4me3. Functions to modulate the efficiency of pre-mRNA splicing CC in part through physical bridging of spliceosomal components to H3K4me3 CC (By similarity). Required for maintaining open chromatin and CC pluripotency in embryonic stem cells (PubMed:19587682). Is also CC associated with histone deacetylase (HDAC) activity (PubMed:12890497). CC {ECO:0000250|UniProtKB:O14646, ECO:0000269|PubMed:12890497, CC ECO:0000269|PubMed:19587682}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12; CC -!- SUBUNIT: Component of the SAGA complex (By similarity). Specifically CC interacts with methylated H3K4me2 and H3K4me3. Interacts with the FACT CC complex, the PAF complex and the U2 snRNP. Interacts directly with CC PAF1, SFA3A1, SFA3A2, SFA3A3, SNF2 and SSRP1 (By similarity). Interacts CC with BCLAF1, NCoR, SRP20 and SAFB. {ECO:0000250, CC ECO:0000269|PubMed:10199952, ECO:0000269|PubMed:12890497, CC ECO:0000269|PubMed:19587682}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10199952, CC ECO:0000269|PubMed:7739555}. Cytoplasm {ECO:0000269|PubMed:7739555}. CC Note=Is released into the cytoplasm when cells enter mitosis and is CC reincorporated into chromatin during telophase-cytokinesis CC (PubMed:7739555). CC -!- TISSUE SPECIFICITY: Abundance is higher in cells representing early CC stages of the B-lymphoid lineage such as pre-B and B-cells, than in CC cells representing mature plasmacytes or other cell lineages such as CC fibroblasts. CC -!- DOMAIN: The 2 chromodomains are involved in the binding to the histone CC H3 methyllysine at position 4 (H3K4me3). CC {ECO:0000250|UniProtKB:O14646}. CC -!- DOMAIN: The CHD1 helical C-terminal domain (CHCT) binds DNA and CC nucleosomes. {ECO:0000250|UniProtKB:O14646}. CC -!- SIMILARITY: Belongs to the SNF2/RAD54 helicase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L10410; AAB08486.1; -; mRNA. DR EMBL; CH466630; EDL20454.1; -; Genomic_DNA. DR EMBL; BC115822; AAI15823.1; -; mRNA. DR CCDS; CCDS28416.1; -. DR PIR; A47392; A47392. DR RefSeq; NP_031716.2; NM_007690.3. DR AlphaFoldDB; P40201; -. DR SMR; P40201; -. DR BioGRID; 198693; 4. DR IntAct; P40201; 1. DR STRING; 10090.ENSMUSP00000024627; -. DR iPTMnet; P40201; -. DR PhosphoSitePlus; P40201; -. DR SwissPalm; P40201; -. DR EPD; P40201; -. DR jPOST; P40201; -. DR MaxQB; P40201; -. DR PaxDb; 10090-ENSMUSP00000024627; -. DR PeptideAtlas; P40201; -. DR ProteomicsDB; 279072; -. DR Pumba; P40201; -. DR Antibodypedia; 25129; 238 antibodies from 35 providers. DR DNASU; 12648; -. DR Ensembl; ENSMUST00000024627.14; ENSMUSP00000024627.8; ENSMUSG00000023852.15. DR GeneID; 12648; -. DR KEGG; mmu:12648; -. DR UCSC; uc008aou.2; mouse. DR AGR; MGI:88393; -. DR CTD; 1105; -. DR MGI; MGI:88393; Chd1. DR VEuPathDB; HostDB:ENSMUSG00000023852; -. DR eggNOG; KOG0384; Eukaryota. DR GeneTree; ENSGT00940000156579; -. DR HOGENOM; CLU_000315_8_1_1; -. DR InParanoid; P40201; -. DR OMA; WVQIRDD; -. DR OrthoDB; 5482994at2759; -. DR PhylomeDB; P40201; -. DR TreeFam; TF300674; -. DR BioGRID-ORCS; 12648; 13 hits in 88 CRISPR screens. DR ChiTaRS; Chd1; mouse. DR PRO; PR:P40201; -. DR Proteomes; UP000000589; Chromosome 17. DR RNAct; P40201; Protein. DR Bgee; ENSMUSG00000023852; Expressed in embryonic post-anal tail and 258 other cell types or tissues. DR ExpressionAtlas; P40201; baseline and differential. DR GO; GO:0000785; C:chromatin; IBA:GO_Central. DR GO; GO:0005737; C:cytoplasm; ISO:MGI. DR GO; GO:0000228; C:nuclear chromosome; ISO:MGI. DR GO; GO:0005634; C:nucleus; ISO:MGI. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0016887; F:ATP hydrolysis activity; IBA:GO_Central. DR GO; GO:0140658; F:ATP-dependent chromatin remodeler activity; IBA:GO_Central. DR GO; GO:0003682; F:chromatin binding; IBA:GO_Central. DR GO; GO:0003677; F:DNA binding; IBA:GO_Central. DR GO; GO:0004386; F:helicase activity; NAS:UniProtKB. DR GO; GO:0042393; F:histone binding; IBA:GO_Central. DR GO; GO:0035064; F:methylated histone binding; ISO:MGI. DR GO; GO:0006325; P:chromatin organization; NAS:UniProtKB. DR GO; GO:0006338; P:chromatin remodeling; IGI:MGI. DR GO; GO:0034728; P:nucleosome organization; IBA:GO_Central. DR GO; GO:0043923; P:positive regulation by host of viral transcription; ISO:MGI. DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central. DR CDD; cd18666; CD1_tandem_CHD1-2_like; 1. DR CDD; cd18661; CD2_tandem_CHD1-2_like; 1. DR CDD; cd18793; SF2_C_SNF; 1. DR Gene3D; 2.40.50.40; -; 2. DR Gene3D; 1.10.10.60; Homeodomain-like; 1. DR Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1. DR Gene3D; 3.40.50.10810; Tandem AAA-ATPase domain; 1. DR InterPro; IPR040793; CDH1_2_SANT_HL1. DR InterPro; IPR025260; CHD1-like_C. DR InterPro; IPR016197; Chromo-like_dom_sf. DR InterPro; IPR000953; Chromo/chromo_shadow_dom. DR InterPro; IPR023780; Chromo_domain. DR InterPro; IPR023779; Chromodomain_CS. DR InterPro; IPR014001; Helicase_ATP-bd. DR InterPro; IPR001650; Helicase_C. DR InterPro; IPR027417; P-loop_NTPase. DR InterPro; IPR038718; SNF2-like_sf. DR InterPro; IPR049730; SNF2/RAD54-like_C. DR InterPro; IPR000330; SNF2_N. DR PANTHER; PTHR45623:SF7; CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 1; 1. DR PANTHER; PTHR45623; CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 3-RELATED-RELATED; 1. DR Pfam; PF18375; CDH1_2_SANT_HL1; 1. DR Pfam; PF13907; CHD1-like_C; 1. DR Pfam; PF00385; Chromo; 2. DR Pfam; PF00271; Helicase_C; 1. DR Pfam; PF00176; SNF2-rel_dom; 1. DR SMART; SM00298; CHROMO; 2. DR SMART; SM00487; DEXDc; 1. DR SMART; SM01176; DUF4208; 1. DR SMART; SM00490; HELICc; 1. DR SUPFAM; SSF54160; Chromo domain-like; 2. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2. DR PROSITE; PS00598; CHROMO_1; 2. DR PROSITE; PS50013; CHROMO_2; 2. DR PROSITE; PS51192; HELICASE_ATP_BIND_1; 1. DR PROSITE; PS51194; HELICASE_CTER; 1. DR Genevisible; P40201; MM. PE 1: Evidence at protein level; KW ATP-binding; Chromatin regulator; Cytoplasm; DNA-binding; Helicase; KW Hydrolase; Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome; KW Repeat; Transcription; Transcription regulation. FT CHAIN 1..1711 FT /note="Chromodomain-helicase-DNA-binding protein 1" FT /id="PRO_0000080225" FT DOMAIN 270..362 FT /note="Chromo 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00053" FT DOMAIN 387..450 FT /note="Chromo 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00053" FT DOMAIN 491..661 FT /note="Helicase ATP-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00541" FT DOMAIN 790..941 FT /note="Helicase C-terminal" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00542" FT REPEAT 1629..1633 FT /note="1" FT REPEAT 1635..1639 FT /note="2" FT REPEAT 1641..1645 FT /note="3" FT REGION 1..250 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1078..1119 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1322..1407 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1409..1511 FT /note="CHD1 helical C-terminal domain (CHCT)" FT /evidence="ECO:0000250|UniProtKB:O14646" FT REGION 1503..1588 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1600..1657 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1629..1645 FT /note="3 X 5 AA repeats of H-S-D-H-R" FT REGION 1670..1711 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 612..615 FT /note="DEAH box" FT COMPBIAS 12..63 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 64..78 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 92..124 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 133..148 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 162..189 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 190..205 FT /note="Basic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 224..250 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1085..1106 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1328..1342 FT /note="Basic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1343..1386 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1507..1522 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1525..1588 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1692..1711 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 504..511 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00541" FT MOD_RES 214 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 215 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 235 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 239 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 248 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 250 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 469 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1023 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1038 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1079 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1083 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14647" FT MOD_RES 1094 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1096 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1098 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1100 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1159 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1353 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1355 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1356 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1360 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1363 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1373 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14647" FT MOD_RES 1678 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT MOD_RES 1690 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O14646" FT CONFLICT 159 FT /note="S -> L (in Ref. 1; AAB08486)" FT /evidence="ECO:0000305" SQ SEQUENCE 1711 AA; 196385 MW; 51499636E943A856 CRC64; MNGHSDEESV RNGSGESSQS GDDCGSASGS GSGSSSGSSS DGSSSQSGSS DSDSGSDSGS QSESESDTSR ENKVQAKPPK VDGAEFWKSS PSILAVQRSA MLRKQPQQAQ QQRPASSNSG SEEDSSSSED SDDSSSGAKR KKHNDEDWQM SGSGSPSQSG SDSESEEERD KSSCDGTESD YEPKNKVRSR KPQNRSKSKN GKKILGQKKR QIDSSEDEDD EDYDNDKRSS RRQATVNVSY KEDEEMKTDS DDLLEVCGED VPQPEDEEFE TIERVMDCRV GRKGATGATT TIYAVEADGD PNAGFERNKE PGDIQYLIKW KGWSHIHNTW ETEETLKQQN VRGMKKLDNY KKKDQETKRW LKNASPEDVE YYNCQQELTD DLHKQYQIVE RIIAHSNQKS AAGLPDYYCK WQGLPYSECS WEDGALISKK FQTCIDEYFS RNQSKTTPFK DCKVLKQRPR FVALKKQPSY IGGHEGLELR DYQLNGLNWL AHSWCKGNSC ILADEMGLGK TIQTISFLNY LFHEHQLYGP FLLVVPLSTL TSWQREIQTW ASQMNAVVYL GDINSRNMIR THEWMHPQTK RLKFNILLTT YEILLKDKAF LGGLNWAFIG VDEAHRLKND DSLLYKTLID FKSNHRLLIT GTPLQNSLKE LWSLLHFIMP EKFSSWEDFE EEHGKGREYG YASLHKELEP FLLRRVKKDV EKSLPAKVEQ ILRMEMSALQ KQYYKWILTR NYKALSKGSK GSTSGFLNIM MELKKCCNHC YLIKPPDNNE FYNKQEALQH LIRSSGKLIL LDKLLIRLRE RGNRVLIFSQ MVRMLDILAE YLKYRQFPFQ RLDGSIKGEL RKQALDHFNA EGSEDFCFLL STRAGGLGIN LASADTVVIF DSDWNPQNDL QAQARAHRIG QKKQVNIYRL VTKGSVEEDI LERAKKKMVL DHLVIQRMDT TGKTVLHTGS APSSSTPFNK EELSAILKFG AEELFKEPEG EEQEPQEMDI DEILKRAETH ENEPGPLSVG DELLSQFKVA NFSNMDEDDI ELEPERNSKN WEEIIPEEQR RRLEEEERQK ELEEIYMLPR MRNCAKQISF NGSEGRRSRS RRYSGSDSDS ISERKRPKKR GRPRTIPREN IKGFSDAEIR RFIKSYKKFG GPLERLDAIA RDAELVDKSE TDLRRLGELV HNGCVKALKD SSSGTERAGG RLGKVKGPTF RISGVQVNAK LVIAHEDELI PLHKSIPSDP EERKQYTIPC HTKAAHFDID WGKEDDSNLL IGIYEYGYGS WEMIKMDPDL SLTHKILPDD PDKKPQAKQL QTRADYLIKL LSRDLAKREA QRLCGAGGSK RRKTRAKKSK AMKSIKVKEE IKSDSSPLPS EKSDEDDDKL NDSKPESKDR SKKSVVSDAP VHITASGEPV PIAEESEELD QKTFSICKER MRPVKAALKQ LDRPEKGLSE REQLEHTRQC LIKIGDHITE CLKEYSNPEQ IKQWRKNLWI FVSKFTEFDA RKLHKLYKHA IKKRQESQQN SDQNSNVATT HVIRNPDMER LKENTNHDDS SRDSYSSDRH LSQYHDHHKD RHQGDSYKKS DSRKRPYSSF SNGKDHREWD HYRQDSRYYS DREKHRKLDD HRSREHRPSL EGGLKDRCHS DHRSHSDHRM HSDHRSSSEH THHKSSRDYR YLSDWQLDHR AASSGPRSPL DQRSPYGSRS PFEHSAEHRS TPEHTWSSRK T //